WHAT IS CANNABITRIOL?
Cannabitriol (CBT) is a chemical compound found in the cannabis plant. It is one of the 130 (and increasing) CBD compounds that exist. It is speculated to have an intoxicating effect due to the common functions of its sister compounds (THC). It shares a similar chemical structure to the tetrahydrocannabinol (THC).
CBT was first discovered in 1966 following a study of the cannabinoid compound. Due to its scarce and pervasive nature, researchers have failed to get enough details about the compound.
Successfully, in 2014, a Jamaican researcher was able to isolate the compound while working to identify and name other compounds. Its functionality, like Cannabichromevarin (CBCV), is still yet to be discovered.
Like every other strain of cannabinoid that exist, CBT is obtained from the cannabis plant through its chemical formation. It can also undergo the process of decarboxylation.
A futuristic bet for the win can be placed on CBT alongside other cannabinoids. The medical field and researchers are proving, day in, day out, that the plant cannabis, amidst its effect along the lines of wrong usage, is beneficial to the human health in fighting diseases and pushing the medical field forward.
The world of CBT is yet to be unlocked.
HOW DOES CBT WORK?
Researchers still don’t know how exactly CBT functions. Its similar structure to THC has bred some speculations that both compounds will have similar functions, such as being psychoactive or having a therapeutic benefit in treating chronic diseases.
But CBT has both of its alcoholic groups as alcohol (the distinct function between CBT & THC), meaning that there is a difference in what we should expect from this compound in terms of benefits and effect to the field of study and human life.
Noting that CBD strains are said to contain two major alcoholic groups, alcohol and phenol, it is therefore not advisable to speculate and assume the functions of CBT without proper research and clinical test results.
POSSIBLE THERAPEUTIC BENEFITS
For now, work is still being done on the strain, and the future will tell how advantageous or dangerous the strain will be to humans.
The UN Convention on Psychotropic Substances designed to control psychoactive drugs suggests a free speculative field around CBT and begs for more clinal trials to be conducted before any therapeutic effects can be slated.
Therefore, it is currently impossible to answer for a fact if CBT is good for medicine or has a psychoactive effect.
Although, if history has taught us anything, it is that the chemical compound “CBD” has its benefits to therapy, medicine, and man and also its detriments.
It is then not a far fetch assumption that CBT will follow in the same line of its sisters.
- Unlike other forms of chemical compounds found in the cannabis plant, CBT is rarely found and doesn’t exist in all cannabis plants.
- Due to the similarity in characteristics and chemical structure, CBT often can be overlooked as THC.
- It doesn’t contain phenol, unlike other CBD compounds, making its distinct identifier chemically based.
Elsohly M.A, El-Feraly FS, Turner CE. Isolation and characterization of (+)-cannabitriol and (-)-10-ethoxy-9-hydroxy-delta 6a[10a]-tetrahydrocannabinol: two new cannabinoids from Cannabis sativa L. extract. Lloydia. 1977;40(3):275-280.
Chan WR, Magnus KE, Watson HA. The structure of cannabitriol. Experientia. 1976;32(3):283-284. doi:10.1007/BF0194079